NEJM Study Deems CRP Significant, Compared With Other Cardiac Markers
This article was originally published in The Gray Sheet
Executive Summary
A recent New England Journal of Medicine study identifying C-reactive protein as a significant marker of coronary heart disease risk may prove to be a boon for CRP diagnostic manufacturers